NT5E and acute lymphoblastic leukemia: By analyzing COG trial P9906, high expression of BMPR1B, CTGF, TTYH2, IGJ, NT5E (CD73), CDC42EP3, and TSPAN7 was found to be associated with poor outcomes in precursor-B ALL patients [34].